Stock IMUC EOM PHARMACEUTICALS HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News EOM Pharmaceuticals Holdings, Inc.

Equities

IMUC

US4525364026

Market Closed - OTC Markets
Other stock markets
 14:40:05 10/05/2024 BST 		5-day change 1st Jan Change
0.21 USD +40.00% Intraday chart for EOM Pharmaceuticals Holdings, Inc. +14.13% -9.48%
2023 EOM Pharmaceutical Holdings Announces Topline Results of Its Covid-19 Clinical Trial of Eom613 in Brazil CI
2023 EOM Pharmaceuticals Holdings, Inc. has withdrawn its IPO in the amount of $15 million. CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
EOM Pharmaceutical Holdings Provides an Update on its Lead Drug Candidate EOM613
PR
EOM Pharmaceutical Holdings Announces Topline Results of its COVID-19 Clinical Trial of EOM613 in Brazil
PR
EOM Pharmaceutical Holdings Announces Topline Results of Its Covid-19 Clinical Trial of Eom613 in Brazil
CI
EOM Pharmaceuticals Holdings, Inc. has withdrawn its IPO in the amount of $15 million.
CI
EOM Pharmaceuticals Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
ImmunoCellular Therapeutics Ltd. has Changed its Name to EOM Pharmaceuticals Holdings, Inc
CI
EOM Pharmaceuticals Holdings, Inc. announced that it has received $0.75 million in funding
CI
EOM Pharmaceuticals Holdings, Inc. announced a financing transaction
CI
EOM Pharmaceuticals Holdings, Inc. has filed an IPO in the amount of $25 million.
CI
ImmunoCellular Therapeutics, Ltd. Auditor Raises 'Going Concern' Doubt
CI
ImmunoCellular Therapeutics, Ltd. Auditor Raises 'Going Concern' Doubt
CI
EOM Pharmaceuticals, Inc. And Immunocellular Therapeutics, Ltd. Announce Entry Into And Close Of Definitive Merger Agreement
PR
EOM Pharmaceuticals, Inc. acquired ImmunoCellular Therapeutics, Ltd. in a reverse merger transaction.
CI
ImmunoCellular Therapeutics : Announces Application for Continued Public Quoting on the Over-the-Counter (OTC) Market
PR
Reverse Split: 1 of 10
FA
ImmunoCellular Therapeutics, Ltd.(AMEX:IMUC) dropped from S&P TMI Index
CI
ImmunoCellular Therapeutics, Ltd. Announces Executive Changes, Effective October 15, 2018
CI
ImmunoCellular Therapeutics, Ltd. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2018
CI
ImmunoCellular Therapeutics Is Considering Strategic Alternatives
CI
ImmunoCellular Therapeutics, Ltd. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2018
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IMUC Stock
  4. News EOM Pharmaceuticals Holdings, Inc.